Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
214.01
-2.89 (-1.33%)
At close: Oct 29, 2025, 4:00 PM EDT
216.27
+2.26 (1.06%)
After-hours: Oct 29, 2025, 7:53 PM EDT
Danaher Revenue
Danaher had revenue of $6.05B in the quarter ending September 26, 2025, with 4.40% growth. This brings the company's revenue in the last twelve months to $24.27B, up 2.22% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$24.27B
Revenue Growth
+2.22%
P/S Ratio
6.32
Revenue / Employee
$385,206
Employees
63,000
Market Cap
151.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
DHR News
- 2 days ago - Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR - PRNewsWire
- 3 days ago - DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR - GlobeNewsWire
- 5 days ago - Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 7 days ago - These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings - Benzinga
- 7 days ago - Danaher: Regaining Growth Momentum - Seeking Alpha
- 7 days ago - Danaher Still A Hold: Good Q3 Results Alone Don't Make A Great Investment - Seeking Alpha
- 8 days ago - Danaher Corporation (DHR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors? - Invezz